Michael Mannstadt

Case records of the Massachusetts General Hospital. Case 7-2007. A 59-year-old woman with diabetic renal disease and nonhealing skin ulcers.

Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism.

Rapid detection of intact FGF-23 in tumor tissue from patients with oncogenic osteomalacia.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism.

Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism.

Effects of phosphate binders in moderate CKD.

Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations.

Long-term follow-up of patients with hypoparathyroidism.

Germline mutations affecting Gα11 in hypoparathyroidism.

Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.

Case records of the Massachusetts General Hospital. Case 24-2014. A 27-year-old man with severe osteoporosis and multiple bone fractures.

Hypoparathyroidism and central diabetes insipidus: in search of the link.

Hypoparathyroidism - disease update and emerging treatments.

A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.

Diphtheria Toxin- and GFP-Based Mouse Models of Acquired Hypoparathyroidism and Treatment With a Long-Acting Parathyroid Hormone Analog.

Management of Hypoparathyroidism: Present and Future.

Epidemiology and Diagnosis of Hypoparathyroidism.

Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.

Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.

Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2.

Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate.

Knockin mouse with mutant Gα11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors.